Invited Talks


  1.  The Annual Alpha-Synuclein Summit organized by the Michael J Fox Foundation, New York, USA, February 16th, 2017.
  2. Oxford University, Oxford Parkinson’s Disease Center Seminar Series, Oxford, UK, May 16th, 2017
  3. Cambridge University, Department of Chemistry, Cambridge, UK May, 2017
  4. Inauguraal symposium of the Institute of Biostructural Imaging of Neurodegeneration, Goettingen, Germany, May 30-31, 2017.
  5. 2017 FASEB Science Research Conference on Protein Aggregation in Health & Disease, Steamboat Springs, Colorado, USA, June 11-16th, 2017
  6. The Latsis/EPFL BMI Symposium ‘Degeneration of Neuronal Circuits’, EPFL, September 4-5, 2017
  7. 20 years of Alpha-Synuclein in Parkinson’s disease and related synucleinopathies; from the bedside to the bench and back to the patient. Athens, Vravrona, September 7-10, 2017
  8. Gordon Research Conference, Chemistry and Biology of Peptides GRC, February 21-26, 2016, Ventura, CA, USA
  9. CHDI Therapeutic Conference, Feb 22-23, 2016, Palms Spring, CA, USA
  10. Qatar Foundation Annual Research Conference; Biomedical and Health Research in Qatar; Translating Challenges into Competitive Advantages and Economic Opportunities. Session organizer and moderator of the panel discussion
  11. UCB Super Network Conference, March 13-15th, 2016, London, UK.
  12. Keynote Lecture: Wilder-Penfield Memorial Lecture “Precision Medicine applied to
  13. Neurodegenerative Diseases” at Middle East Annual Assembly meeting, “Precision Medicine: A new Era towards Personalized Healthcare” American University of Beirut, May 13-15th, Beirut Lebanon
  14. Federation of European Neuroscience Societies Forum of Neuroscience; alpha-synuclein prion like forms as target for therapy in Parkinson’s disease and other synucleinopathies, July 5th, 2016.
  15. First Translational Neuroscience Summer School organized by Technical University of Munich, The International Parkinson and Movement Disorder Society (MDS), and the German Academic Exchange Service (DAAD) in El Gouna, Egypt, September 6-8th, 2016.
  16. Technical University Munich, Munich Cluster for Systems Neurology Seminar series, September 20th, 2016
  17. Diabetes Leadership Fourm: Qatar National Diabetes Research Strategy, September 26th, 2016
  18. 5th Annual International Chemical Biology Society Conference (ICBS 2016 Conference), Wisconsin Madison, USA, October 24-26th, 2016
  19. Diabetes Leadership Forum, Qatar National Research Strategy, Doha, Qatar, September 26-27th, 2016.


  1. International Parkinson’s and Movement Disorders Society- European Section. Alpha-Synulcein: the Gateway to Parkinsonism, Innsbruck, Austria, Feb 11-13, 2015
  2. American Chemical Society National Meeting taking place during the week of 22-26, March 2015 in Denver, CO.
  3. Molecular Mechanisms of Neurodegeneration in hereditary disease (VI meeting), May 28-30th, 2015 in Milano Italy
  4. FASEB Molecular Mechanisms and Physiological Consequences of Protein Aggregation, Jun 21- 26, 2015, Palm Beach FL.
  5. First Sino-Swiss Symposium in Translational Medicine, June 29th – July 1st, Tianjin International Academy of Biomedicine, Tianjin- China.
  6. Lead Organizer and Lecturer: Advanced Neuroscience School on Protein Misfolding and Accumulation: Cellular Mechanisms, Imaging and Drug Development, August 22-29th, 2015.
  7. Keynote Speaker: Life Science PhD days orgSanized by University of Luxembourg, September 21st -22nd , 2015 in Belval/ Luxembourg.
  8. Grand Challenges in Parkinson’s Disease Annual Meeting, September 30th – October 1st, 2015. Van Andel Research Institute, Grand Rapids-Michigan, USA
  9. ICBS-ECBS International Chemical Biology Society Meeting, October 7-9th, 2015, in Berlin Germany
  10. University of Pennsylvania Department of Biochemistry and Molecular Biophysics (BMB), Nov 17th, 2015, Pennsylvania, USA.


  1. Swiss Society of Neuroscience Annual Meeting, Bern, Switzerland, January 25th, 2013
  2. Joint 2014 Keystone Symposia on Parkinson’s Disease: Genetics, Mechanisms and Therapeutics/Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel. These meetings will be held March 2-7, 2014
  3. International Symposium “New frontier of molecular neuropathology”, Riken, Tokyo, March 16-17, 2014
  4. Barcelona Biomed Conference on Amyloid and Alzheimer’s disease, Barcelona July 10-11th, 2014
  5. EMBL Chemical Biology Conference, Heidelberg, Germany, August 20-23rd, 2014
  6. Science and Technology Society Forum, Kyoto, Japan, October 6-8th, 2014
  7. Brain Conference 2014, the joint conference of Korean Society for Brain and Neural Science, Korean Society for Neurodegenerative Diseases, and Asian Congress of Neuropathology. The conference will be held in Seoul, Korea on Nov 6th-8th, 2014. ” Targeting conformations in diagnosis and therapy for neurodegenerative diseases.”
  8. Harvard Arab Alumni Association. Harvard University “Re-emergence of Science in the Middle East”, Boston, USA, November 6-9, 2014.
  9. IBRO-MENA Neuroscience School in Neurogenetics, December 10-16th, 2014, QBRI, Doha-Qatar
  10. IBRO-MENA Neuroscience Research Symposium, QBRI, Doha-Qatar


  1. Department of Neurology and Neurological Sciences Annual Retreat, Stanford University Jan, 2013.
  2. Genentech, San Francisco, January 22nd, 2013.
  3. International Conference on “Alpha-synuclein in Parkinson’s disease and related neurodegenerative diseases: From Mechanisms to Therapeutic Strategies”, March 1-3rd, 2013.
  4. AD/PD Conference, Florence Italy, March 6-10th, 2013
  5. Young Global Leaders Future Development Summit, March 17-19th, 2013
  6. American Physical Society Annual Meeting, “Physics of Proteins II: Protein Association, Interaction,and Aggregation.” Baltimore, USA, March 18-22nd, 2013
  7. 5th Chemical protein synthesis (CPS) Meeting, Vienna, Austria, April 3-6th, 2013
  8. CHDI’s 8th Annual HD Therapeutics Conference – Venice, Italy, April 8-11, 2013
  9. Neuroscience School of Advanced Studies, Protein Aggregation Spectrum Disorders, June 15-23, 2013
  10. European Biophysical Society, Lisbon, Portugal, July 13-17th, 2013.
  11. 2013 FASEB Summer Research Conference on Molecular Mechanisms and Physiological Consequences of Protein Aggregation.
  12. MEFOPA & Neurasync Final Meeting September 19‐21 2013, Rome
  13. Stepping Stone Symposium, China, October 17-21, 2013
  14. α-Synuclein Summit organized by the Michael J Fox Foundation, Nov 7-8th, 2013 New York, USA
  15. Bioeconomy Rome International Conference, Rome, No 25-26
  16. 6th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East, Istanbul, Turkey, October 23-24th, 2013
  17. 4th Scandinavian Amyloid Symposium, Lund University, Nov 18-20, 2013, Lund, Sweden
  18. Brain Forum, Dec 3-4th, 2013, Jeddah, Saudi Arabia


  1. MRC National Institute for Medical Research, London, UK, February 2nd, 2012
  2. Department of Neurobiology, Reed Neurological Research Center, UCLA, LA, USA, March 2nd, 2012.
  3. Neuroscience School of Advanced Studies, A course on “Synucleinopathies”, April 17-18th, 2012
  4. 2nd Prato Conference on Pore Forming Proteins, Parto, Italy, April 18-20th, 2012
  5. CECAM workshop about “Anchoring simulations to experiments: challenges for understanding and treating Alzheimer’s disease”, Paris, France, May 14-22nd, 2012
  6. Jazan University Research Symposium, Jazan, Saudi Arabia, May 27-28th, 2012
  7. Stepping Stone Symposia. “First Conference on Cancer and Neurodegenerative diseases”, Zurich, Switzerland, June 20-22nd, 2012
  8. Department of Chemistry, Technische Universität München, Germany, June 26th, 2012
  9. Neurasync training course, Max Plank Institute, Gottengen, Germany, June 26th, 2012
  10. 2nd Gordon Research Conference “Intrinsically Disordered Proteins”, Vermont, USA. July 8 – 13, 2012.
  11. 5th international Symposium on Macrophage Migration Inhibitory Factor (MIF), Louisville, KY, USA, Sept 13, 2012
  12. ‘100 Years Lewy Bodies – Where are we now?’ a special symposium organized in the historical building of the Dept of Psychiatry in Munich, Germany, where Friedrich Jacob Heinrich Lewy discovered the Lewy Bodies 100 yrs. ago in 1912. Munich, Germany, September 15th, 2012.
  13. Neuromodel Symposium, Kings College London School of Medicine, September 20-21st, 2012
  14. School on Biological Physics, Rio de Janeiro, Brazil, September, 30- October 7th, 2012,
  15. Post-Translational Modifications: Detection and Physiological Role, Granlibakken, Lake Tahoe, October 11-14, 2012
  16. “Yemen in Transition: Challenges and Opportunities”, Harvard University, USA, October 19-21, 2012
  17. Scripps Research Institute La Jolla, San Diego, Nov 16th, 2012
  18. SASTA-Arab League Conference, Cairo, Egypt, Dec 19-21st, 2012
  19. TEDx Sanaá, Sanaá, Yemen, Dec 31st, 2012.


  1. Keynote speaker. University of Tokyo, Centre for Medical System Innovation (CMSI) annual symposium, Tokyo, Japan, Feb 22nd, 2011.
  2. 4th international Symposium on Macrophage Migration Inhibitory Factor (MIF), New Haven, USA, May 11-14th, 2011
  3. 10th Congress of the French Neuroscience Society, “ New experimental tools and therapies for Parkinson’s disease”, Marseille, France, May 25th, 2011
  4. International Society of Neuroscience meeting “From genes to pathogenesis: The evolving spectrum of synucleinopathies”. Athens, Greece, Sep 4-6, 2011.
  5. Faculty of Sciences, Jordan University of Science and Technolgoy, Jordan, Oct , 2011
  6. King Abdullah University of Science and Technology, Saudi Arabia, Nov 27th, 2011.


  1. Boston Biomedical Research Institute, Cambridge, Boston, January 11th, 2010.
  2. Alpha Synuclein Summit, Organized by Michael J. Fox Foundation, New York, USA, January 13-14, 2010.
  3. Genentech Inc. San Francisco, CA, USA, January 15, 2010
  4. Biophysics School on the Molecular Mechanisms of Neurodegeneration
  5. Molecular Mechanisms of Neurodegeneration” Venice, Italy, January 25th, 2010.
  6. Department of Biochemistry, University of Bologna, Italy, April 20-21st, 2010
  7. Global Redesign Summit organized by the World Economic Forum and the foreign ministry of the state of Qatar. May 21-22nd, 2010.
  8. Eli Lily Pharmaceuticals, Indianapolis, USA, July 29th, 2010.
  9. Parkinson’s Disease Therapeutics Conference organized by the Michael J Fox Foundation and the New York Academy of Sciences, New York, USA. October 6th, 2010.
  10. Keynote speaker: Selected by the students to give the keynote lecture at the 1st Instituto de Tecnologia Química e Biológica (ITQB) PhD Students Conference, The New University of Lisbon, October 21-22nd, 2010, Portugal.
  11. One of 5 panelist at the Future of Education Summit, session (Closing the GAP), World Economic Forum on the Middle East and North Africa, Marrakech, Morocco, Oct 25-28, 2010
  12. α-Synuclein in health and disease 2010, San Diego, USA, November 11-12th, 2010


  1. Boehringer Ingelheim Pharma GmbH & Co. KG, January 21-22, 2009
  2. Structure of Amyloid Fibrils and Mechanism of their Formation, Halle (Saale), Germany, 8-11 February 2009.
  3. Workshop of the International Graduate College “Molecular Complexes of Biomedical Relevance” Braunschweig, Germany, 25–26 April 2009
  4. Conférences Jacques Monod: “Protein folds in infectious and neurodegenerative diseases” Aussois (Savoie), France, 25-29 April 2009.
  5. World Economic Forum on the Middle East, Dead Sea, Jordan, May 15-17, 2009
  6. University of Leuven, Faculty of Sciences, Department of Chemistry, Leuven, Belgium, May 27th, 2009
  7. 4th European Society of Neurochemistry Conference on “Advances in Molecular Mechanisms of Neurological Diseaeses”, Mechanisms in synucleinopathies Leipzig, Germany, July 11-14th, 2009.
  8. Genentech, San Francisco, CA, June 24th, 2009
  9. Eli Lilly, Indiana, June 26th, 2009.
  10. FASEB Summer Research Conference on “Amyloid Fibril Formation and Protein Misfolding: Molecular Mechanisms and Cellular Effects”, Snowmass Village, Colorado, USA. June 28 – July 3, 2009.
  11. International Conference of Alzheimer’s Disease (ICAD), Featured symposium on “Pathophysiological role of alpha-synuclein in Parkinson’s disease and dementia”.Vienna, Austria, July 14th, 2009
  12. The International Society for Neurochemistry, “Synucleinopathies – mechanisms, models and therapeutic strategies”, Bejing, Aug 29-30, 2009.
  13. Japanese-Switzerland Biomolecular Chemistry Symposium, Tokyo, Japan. Sept 11-12th.
  14. Seoul National University, Department of Pharmacology, Seoul, South Korea, Sept 14th, 2009.
  15. KonkuK University, Department of Biomedical Sciences, Institute of Biomedical Sciences and Technology, Seoul, South Korea, Sept 16, 2009.
  16. Institut de Recherche en Ophtalmologie (IRO), Sion, Switzerland, Sept 22, 2009.
  17. Summar School on Dopaminergic Neurons, Trieste, Italy, October 5-6, 2009.
  18. 3rd International MIF Symposium, Schloß Hochhausen, Germany, December 3-5, 2009


  1. Grand Challenge Speaker, “Institute of Complex Adaptive Matter Annual Conference”, Santa Fe, New Mexico, January 14-17th, 2008
  2. Elan Pharamceuticals, San Francisco, January 13th, 2008
  3. 1st International Conference on Drug Design and Discovery, Dubai, UAE, Feb 3-6, 2008.
  4. Fassberg lecturer, Max Plank Institute for Biophysical Chemistry, Göttingen, Germany, February 19th, 200
  5. Institute De Biologie Structurale et Microbiologie CNRS / IBSM, Marseille, France, March 5th, 2008
  6. Annual Meeting of the German Society for Cell Biology, A symposium on Pathologic aggregation of proteins. Marburg, Germany, March 12-15, 2008
  7. Shanghai Medical College of Fudan University, Shanghai, China, March 28th, 2008
  8. Future Medicine, Faculty of Medicine, Alexandria University, Egypt, May 14-16, 2008.
  9. World Economic Forum (WEF), WEF, Face-to-Face meeting with Global Leadership Fellows, Cologny, Geneva, Switzerland, June 10th, 2008.
  10. 6th FENS (Federation of European Neuroscience Societies) Conference: Symposium on Molecular mechanisms in Parkinson¹s disease and other synucleinopathies. 6th FENS, Geneva, Switzerland, July 12-16, 2008
  11. α-Synuclein in Health and Disease, Lausanne, Switzerland, September 24-26th, 2008.
  12. International Symposium on Medicinal Chemistry (EFMC-ISMC 2008), Vienna, Austria, August 31 – September 4, 2008
  13. Organic Chemistry and Biochemistry Colloquium, Department of Biochemistry, Technical University of Munich, Germany, October 30th, 2008.
  14. Michael J. Fox Foundation for Parkinson’s Research, New York, USA, November 8th, 2008.
  15. Merck/Serono, Geneva, Nov 27th, 2008.
  16. Institut de Recerca Biomèdica Parc Científic de Barcelona, Barcelona, Spain, December 5th, 2008.
  17. New York Academy of Sciences Symposium “”Tau and Beyond: Phosphorylation in Neurodegenerative Disorders”, New York, USA, December 9th, 2008.
  18. United Arab Emirates University, Faculty of Medicine Neuroscience Seminar Series, December 23rd, 2008.


  1. Keynote Speaker, Lake Geneva Innovation Society (LGIS) Gala Dinner, Geneva, Switzerland, January 23rd.
  2. Verbier Neural Workshop. “Nutrition, Exercise and Neurodegenerative Diseases”, January 28-31st, 2007.
  3. The Ringber Meeting 2007. “Molecular basis of toxic protein conformation”, Ringberg Castle, Bavaria, Germany, February 18-21st, 2007.
  4. Wyeth Research, Neuroscience Discovery Research, Princeton, New Jersey, USA, March 1-2.
  5. Banbury Center, Cold Spring Harbor “When is Amyloid Functional and When is Amyloidogenesis Pathological? New York, USA, March 11-14th.
  6. Third meeting on the “Molecular Mechanisms of Neurodegeneration”, Milan, Italy, May 19-21, 2007.
  7. Technical University of Braunschweig, Institute of Biochemistry and Biotechnology, May 23, 2007
  8. Keynote Speaker, EndoNeuro meeting: The annual Dutch meeting for molecular and cellular neuroscience. “Molecular aspects of alpha-synuclein aggregation in Neurodegeneration”, Doorwerth, The Netherland, June 5-8th, 2007
  9. University of Twente, Enschede, The Netherlands, June 8, 2007.
  10. Plenary speaker, Frontiers in Chemical Biology Symposium, University of Strathclyde, Scotland, UK, June 16, 2007.
  11. Plenary Speaker, New Frontiers in Basic and Clinical Research in Parkinson’s disease and other synucleinopathies Queensland, Australia, July 5-6, 2007.
  12. Protein Assembly in Materials, Biology, and Medicine, Direct impact on biological nanosciences, Crete, Greece, Capsis Hotel, July 7-10.
  13. FENS Summer School, Molecular Strategies for treating neurodegenerative diseases, Ofir, Portugal, July 8-15, 2007.
  14. Alpine Meeting “ Molecular basis of disease”, Valens Switzerland, August 16-19th
  15. 9th International Conference on Transglutaminases and protein cross linking, Marrakech, Morocco, Sept 1-5, 2007.
  16. Max Planck Institute for Biophysical Chemistry, Department of Molecular Biology, Göttingen, Germany, Oct 23rd 2007.
  17. INSERM U679 (former U289) Thérapeutique et Neurologie Expérimentale Hôpital de la Pitié-Salpêtrière, Nov 9th 2007
  18. Biophysics Colloquia, Department of Chemistry, Cambridge University, Cambridge, UK, Nov 30th, 2007.
  19. Qfirst2007 Doha Conference, Towards Partnership in Research with Arab Expatriate
  20. Scientists to Achieve Sustainable Development in Qatar, Doha, December 10-12th, 2007.


  1. Novartis Pharmaceuticals, Basel, Switzerland. January 10th, 2006.
  2. Biozentrum, University of Basel, January 24th, 2006.
  3. Workshop on amyloid formation. The structure of amyloid aggregates, the mechanism of their formation and the molecular basis of cell dysfunction Firenze, Italy March 25-28, 2006.
  4. The annual meeting of the German Society of Human Genetics, “Molecular mechanisms in Huntington disease protein misfolding”, Heidelberg, Germany, March 8, 2006.
  5. School of Sciences, Taiz University, Republic of Yemen, April 20th, 2006
  6. International Conference “From Sold State to Biophysics III” Dubrovnik, Croatia, June 24-July 1st, 2006.
  7. Max Planck Institute for Biophysical Chemistry, Department of Molecular Biology, Göttingen, Germany, May 21, 2006.
  8. Symposium on “Protein Transport, Synaptic Function and Neurodegenerative Diseases”. European Neuroscience Institute, Göttingen, Germany, Sep 3, 2006.
  9. The European BioAlpine Convention, Grenoble- Keynote Speaker, France, October 6, 2006.
  10. Department of Theoretical Biology, Peking University, Beijing, China, November 19-21st, 2006.
  11. Visiting Professor, Universiti Teknologi Malaysia, Skudai, Johor, Malaysia, November 21-24, 2006.


  1. Ph.D. Course in Protein Fibrillation and Aggregation. Aalborg University, Denmark, May 17-20.
  2. The Second Japan-Switzerland Workshop on Biomechanics “New Trends in Biomechanics: from Biomolecule to Tissue. Kyoto, Japan. September 12 -16, 2005.
  3. University of Geneva, Department of Biochemistry and Structural Biology Seminar, Geneva, June 17th.
  4. The 3rd Lemanic Neuroscience Conference, Diablerets, Switzerland.
  5. Nathan Shock Center Conference on Aging: The Role of Protein Misfolding and Aggregation on Aging and Age-Related Disorders. San Antonio, Texas, October 27-30, 2005.
  6. International Neuroscience conference in the United Arab Emirates, November 26-29, 2005.
  7. FENS/HERTIE winter school. Neurodegenerative Aggregation Disorders: from genes to protein aggregation, neuronal dysfunction and experimental treatments. Kitzbuhel, Austria, December 2005.
  8. The Second Japan-Switzerland Workshop on Biomechanics “New trends in Biomechanics: from biomolecule to tissue. Kyoto, Japan. September 12 –16


  1. 10th Neural Workshop Verbier, “Molecular, Cellular and Clinical Aspects of Neurodegenerative Diseases” Verbier, Switzerland, January, 2004.
  2. Institute for Complex Adaptive Matter Workshop. Protein Misaggregation: from Biomolecules to Neurodegeneration. Boston, MA, February 9th- 11, 2004.
  3. Washington University School of Medicine, St. Louis, Alzheimer’s disease research center seminar, April 20th, 2004.
  4. Clark University, Department of Chemistry and Biochemistry. Worcester, MA, April 28th, 2004.
  5. King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, April 30th –May 5th.
  6. Dutch Endo Neuro Psycho meeting of 2004. Annual meeting for scientists of fundamental and clinical endocrinology, neuroendocrinology and neuroscience. Amsterdam, Netherlands June 1-3, 2004
  7. Netherlands Brain Institute, Amsterdam, Netherlands, June 4th, 2004.
  8. Institute de Recerca Biomèdica de Barcelona, Barcelona, Spain, June 10-11th, 2004.
  9. The Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland, June 7th-9th.
  10. Summer Neuropeptide 2004 Conference, Miami, July 5-9, 2004.
  11. Washington University School of Medicine, St. Louis, Department of Biochemistry seminar, July 23th, 2004.
  12. FEBS research course “New molecular strategies to treat neurodegenerative diseases”. Ofir – Portugal, July 17-23, 2004.
  13. University of Texas Health Science Center, San Antonio, Texas. Department of Biochemistry, July 25th, 2004.


  1. Boehringer Ingelheim Fonds Internalional Titisee Conferences “Alzheimer’s and Parkinson’s Disease: From Basic Science to Therapeutic Treatment. Germany, Titise/Black Forest, March 19-23, 2003.
  2. Third Multidisciplinary Workshop: “Self-assembling Peptides & Protein Systems in Biology, Medicine and Engineering” Crete, Greece, August, 2003.
  3. Lady Davis Institute for Medical Research, Montreal, Canada, August 27th, 2003.
  4. Rensselaer Polytechnic Institute, Department of Chemistry Seminar Series. “Protein fibrillogenesis in Neurodegenerative Diseases: From Biophysics to Therapeutic Strategies. Albany, NY September 2nd, 2003.
  5. University of Rhode Island’s Department of Biomedical Sciences, Rhode Island, November 2003.


  1. University of California San Francisco, “Physical Properties of Amyloid Diseases”, San Francisco, CA. December, 25-27 2002
  2. Parkinson’s Institute, “Protein Fibrillogenesis in Parkinson’s Disease”, Sunnyvale, CA.December, 28 2002
  3. Massachusetts Institute of Technology, Department of Biology: “Structural Biology Seminar”, March, 18, 2002.
  4. American Chemical Society National Meeting, “Structural and Mechanistic Aspects of Amyloid Fibril Formation” Orlando Florida, April, 7-11 2002.
  5. FASEB Meeting: “Amyloid and Other Abnormal Protein Processes”, Colorado, June, 15-20 2002.
  6. Biogen,Inc, Cambridge, MA, September, 6th, 2002.
  7. Protein Folding and Disease: The Horizon Symposia “Protein Folding and Disease” organized by Nature Publishing Group and Aventis. Verona, Italy, October, 2-5th 2002.
  8. Elan BioPharmaceuticals, San Francisco, CA, October 13, 2002.
  9. RIKEN Brain Science Institute: The first international workshop of molecular neuropathology “Frontiers in Molecular Neuropathology” Japan, November, 27-29 2002.


  1. King Fahed University of Petroleum and Minerals, Department of Chemistry Seminar, Dhahran, Saudi Arabia, April, 2001.